Autoimmune Disease Diagnostics: Global Markets
Report Scope:
This report aims to study the autoimmune disease diagnostics global market size comprehensively. Current and historical market revenues can be estimated based on the technology, by indication, gender and region.
Report Includes:
41 data tables and 30 additional tables
An overview of the global market landscape related to the autoimmune disease diagnostics
In-depth analysis of global market trends, featuring historical revenue data for 2020-2022, estimated figures for 2023, as well as forecasts for 2028. This analysis includes projections of Compound Annual Growth Rates (CAGRs) spanning through 2028
Evaluation of the current market size and revenue growth prospects specific to autoimmune disease diagnostics, accompanied by a comprehensive market share analysis categorized by technology, indication, gender, and geographical region
Detailed description of autoimmune disorder & therapies, and causes such as intrinsic factors, environmental factors, and lifestyle factors, and insights into new diagnostic pathway for autoimmune and inflammatory disorders
Discussion on role of bioinformatics and biomarkers on autoimmune disorder therapies and information on standardization of test results
Coverage of new product launches in the therapeutics for autoimmune diseases and performance methods in the detection of autoimmune antibodies
Coverage of emerging technologies in autoimmune disease diagnostics, recent developments, future opportunities, patent review, and ESG trends
Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
Detailed profiles of leading market participants, including Abbott, Beckman Coulter Inc., BioMérieux, Siemens Healthcare, F. Hoffmann-La Roche AG, and Thermo Fisher Scientific
- Chapter 1 Introduction
- Study Goals and Objectives
- Reasons for Doing This Study
- What’s New in This Update?
- Scope of Report
- Methodology
- Information Sources
- Secondary Research
- Geographic Breakdown
- Segmentation Breakdown
- Chapter 2 Summary and Highlights
- Market Outlook
- Market Summary
- Chapter 3 Market Overview and Definitions
- Overview: Autoimmune Disease Diagnostics
- Enzyme-|Linked Immunosorbent Assay (ELISA)
- Indirect Immunofluorescence (IIF)
- Multiplex Immunoassays
- Western Blot (Immunoblot)
- Other Technologies
- Indications
- Rheumatoid Arthritis
- Systemic Lupus Erythematosus (SLE)
- Psoriatic Arthritis
- Multiple Sclerosis
- Inflammatory Bowel Disease
- The Global Regulatory Structure for Autoimmune Disease Diagnostics
- Test Validation
- FDA Clearance or Approval
- Good Manufacturing Practices (GMP)
- Labeling and Instructions
- Post-Market Surveillance
- Quality Control and Quality Assurance
- Clinical Utility and Medical Guidelines
- Privacy and Data Security
- Regulatory Scenario
- North American Regulations
- Latin American Regulations
- Asia-Pacific Regulations
- Chapter 4 Market Dynamics
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Chapter 5 Market Breakdown by Region
- Market Overview and Discussion
- North America
- Mexico
- Canada
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia and New Zealand
- Rest of Asia-Pacific
- Rest of the World
- Chapter 6 Market Breakdown by Gender
- Market Overview and Discussion
- Male
- Female
- North American Market by Gender
- European Market by Gender
- Asia-Pacific Market by Gender
- Rest of the World Market by Gender
- Chapter 7 Market Breakdown by Indication
- Market Overview and Discussion
- Type 1 Diabetes
- Rheumatoid Arthritis
- Systemic Lupus Erythematosus (SLE)
- Psoriasis/Psoriatic Arthritis
- Multiple Sclerosis
- Inflammatory Bowel Disease
- Other Indications
- Chapter 8 Market Breakdown by Technology
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Regional Markets
- Indirect Immunofluorescence (IIF)
- Regional Markets
- Immunoblot
- Regional Markets
- Multiplex Immunoassays
- Regional Markets
- Others
- Regional Markets
- Chapter 9 ESG Development
- Introduction
- Environment
- Research Practices
- Supply Chain Sustainability
- Waste Management
- Energy Efficiency
- Social
- Access to Healthcare
- Patient Well-Being
- Community Engagement
- Governance
- Ethical Business Practices
- Compliance with Regulations
- Board Diversity
- Transparency and Accountability
- Case Study
- Roche
- Sustainability at Roche
- Concluding Remarks from BCC Research
- Chapter 10 Emerging Trends and Technologies
- Introduction
- Chapter 11 Competitive Landscape
- Overview
- Industry Scenario
- Company Shares
- Chapter 12 Patent Analysis
- Patent Analysis by Manufacturer
- Chapter 13 Pipeline Analysis
- Clinical Trials
- Chapter 14 M&A and Venture Funding Outlook
- Introduction
- Chapter 15 Company Profiles
- ABBOTT
- BD BIOSCIENCES
- BECKMAN COULTER INC.
- BIOMERIEUX
- BIO-RAD (ABD SEROTEC)
- F. HOFFMANN-LA ROCHE AG
- QUEST DIAGNOSTICS INC.
- SIEMENS HEALTHCARE
- THERMO FISHER SCIENTIFIC INC.
- Chapter 16 Appendix: Acronyms
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook